Annual Shareholders Equity
$10.23 M
-$28.23 M-73.40%
31 December 2023
Summary:
AIM ImmunoTech annual stockholders equity is currently $10.23 million, with the most recent change of -$28.23 million (-73.40%) on 31 December 2023. During the last 3 years, it has fallen by -$51.06 million (-83.30%). AIM annual shareholders equity is now -83.30% below its all-time high of $61.29 million, reached on 31 December 2020.AIM Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$2.91 M
-$3.19 M-52.28%
30 September 2024
Summary:
AIM ImmunoTech quarterly stockholders equity is currently $2.91 million, with the most recent change of -$3.19 million (-52.28%) on 30 September 2024. Over the past year, it has dropped by -$19.69 million (-87.12%). AIM quarterly shareholders equity is now -95.90% below its all-time high of $70.97 million, reached on 31 March 2021.AIM Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AIM Shareholders Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -73.4% | -87.1% |
3 y3 years | -83.3% | -95.3% |
5 y5 years | +97.8% | -79.0% |
AIM Shareholders Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -83.3% | at low | -95.3% | at low |
5 y | 5 years | -83.3% | +97.8% | -95.9% | at low |
alltime | all time | -83.3% | +181.9% | -95.9% | +38.7% |
AIM ImmunoTech Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $2.91 M(-52.3%) |
June 2024 | - | $6.10 M(+26.4%) |
Mar 2024 | - | $4.83 M(-52.8%) |
Dec 2023 | $10.23 M(-73.4%) | $10.23 M(-54.7%) |
Sept 2023 | - | $22.60 M(-25.0%) |
June 2023 | - | $30.14 M(-13.9%) |
Mar 2023 | - | $34.99 M(-9.0%) |
Dec 2022 | $38.47 M(-32.4%) | $38.47 M(-9.9%) |
Sept 2022 | - | $42.70 M(-12.5%) |
June 2022 | - | $48.78 M(-8.5%) |
Mar 2022 | - | $53.30 M(-6.3%) |
Dec 2021 | $56.88 M(-7.2%) | $56.88 M(-8.3%) |
Sept 2021 | - | $62.05 M(-5.3%) |
June 2021 | - | $65.53 M(-7.7%) |
Mar 2021 | - | $70.97 M(+15.8%) |
Dec 2020 | $61.29 M(+356.0%) | $61.29 M(+0.3%) |
Sept 2020 | - | $61.11 M(+30.0%) |
June 2020 | - | $46.99 M(+33.8%) |
Mar 2020 | - | $35.11 M(+161.2%) |
Dec 2019 | $13.44 M(+159.8%) | $13.44 M(-2.9%) |
Sept 2019 | - | $13.84 M(+111.4%) |
June 2019 | - | $6.55 M(+66.6%) |
Mar 2019 | - | $3.93 M(-24.0%) |
Dec 2018 | $5.17 M(-40.5%) | $5.17 M(-19.6%) |
Sept 2018 | - | $6.44 M(-29.2%) |
June 2018 | - | $9.10 M(-10.8%) |
Mar 2018 | - | $10.20 M(+17.2%) |
Dec 2017 | $8.70 M(-43.8%) | $8.70 M(-13.3%) |
Sept 2017 | - | $10.04 M(-2.8%) |
June 2017 | - | $10.33 M(-20.2%) |
Mar 2017 | - | $12.95 M(-16.5%) |
Dec 2016 | $15.50 M(-23.9%) | $15.50 M(-6.8%) |
Sept 2016 | - | $16.63 M(-4.9%) |
June 2016 | - | $17.49 M(-5.0%) |
Mar 2016 | - | $18.41 M(-9.6%) |
Dec 2015 | $20.37 M(-18.5%) | $20.37 M(-12.1%) |
Sept 2015 | - | $23.17 M(-13.4%) |
June 2015 | - | $26.76 M(-0.8%) |
Mar 2015 | - | $26.97 M(+7.9%) |
Dec 2014 | $25.00 M(-14.7%) | $25.00 M(-5.2%) |
Sept 2014 | - | $26.36 M(-10.2%) |
June 2014 | - | $29.37 M(-8.2%) |
Mar 2014 | - | $31.99 M(+9.2%) |
Dec 2013 | $29.30 M(-34.5%) | $29.30 M(-8.9%) |
Sept 2013 | - | $32.15 M(-11.0%) |
June 2013 | - | $36.14 M(-12.7%) |
Mar 2013 | - | $41.38 M(-7.4%) |
Dec 2012 | $44.70 M(+17.7%) | $44.70 M(+22.1%) |
Sept 2012 | - | $36.61 M(+9.2%) |
June 2012 | - | $33.53 M(-7.2%) |
Mar 2012 | - | $36.13 M(-4.8%) |
Dec 2011 | $37.97 M(-17.4%) | $37.97 M(-6.4%) |
Sept 2011 | - | $40.57 M(-7.1%) |
June 2011 | - | $43.67 M(-5.0%) |
Mar 2011 | - | $45.95 M(0.0%) |
Dec 2010 | $45.95 M | $45.95 M(-14.0%) |
Sept 2010 | - | $53.40 M(-4.1%) |
June 2010 | - | $55.69 M(-4.6%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2010 | - | $58.40 M(-0.5%) |
Dec 2009 | $58.70 M(+408.4%) | $58.70 M(-11.5%) |
Sept 2009 | - | $66.31 M(+44.4%) |
June 2009 | - | $45.91 M(+361.6%) |
Mar 2009 | - | $9.95 M(-13.9%) |
Dec 2008 | $11.54 M(-44.9%) | $11.54 M(-9.7%) |
Sept 2008 | - | $12.78 M(-17.9%) |
June 2008 | - | $15.56 M(-14.3%) |
Mar 2008 | - | $18.16 M(-13.3%) |
Dec 2007 | $20.95 M(-15.3%) | $20.95 M(-10.0%) |
Sept 2007 | - | $23.29 M(-12.8%) |
June 2007 | - | $26.72 M(-2.6%) |
Mar 2007 | - | $27.42 M(+10.8%) |
Dec 2006 | $24.75 M(+32.9%) | $24.75 M(+15.2%) |
Sept 2006 | - | $21.48 M(-10.0%) |
June 2006 | - | $23.87 M(-12.1%) |
Mar 2006 | - | $27.17 M(+45.9%) |
Dec 2005 | $18.63 M(-13.6%) | $18.63 M(+35.7%) |
Sept 2005 | - | $13.73 M(-6.8%) |
June 2005 | - | $14.73 M(-14.7%) |
Mar 2005 | - | $17.27 M(-19.9%) |
Dec 2004 | $21.56 M(+133.1%) | $21.56 M(-5.1%) |
Sept 2004 | - | $22.71 M(+61.7%) |
June 2004 | - | $14.05 M(+51.2%) |
Mar 2004 | - | $9.29 M(+0.5%) |
Dec 2003 | $9.25 M(+154.8%) | $9.25 M(+25.7%) |
Sept 2003 | - | $7.36 M(+6.1%) |
June 2003 | - | $6.94 M(+50.7%) |
Mar 2003 | - | $4.60 M(+26.8%) |
Dec 2002 | $3.63 M(-66.3%) | $3.63 M(-27.2%) |
Sept 2002 | - | $4.98 M(-26.2%) |
June 2002 | - | $6.75 M(-27.9%) |
Mar 2002 | - | $9.36 M(-13.0%) |
Dec 2001 | $10.76 M(-7.0%) | $10.76 M(+56.8%) |
Sept 2001 | - | $6.86 M(-16.4%) |
June 2001 | - | $8.21 M(-12.2%) |
Mar 2001 | - | $9.35 M(-19.2%) |
Dec 2000 | $11.57 M(-8.9%) | $11.57 M(-8.4%) |
Sept 2000 | - | $12.64 M(-9.9%) |
June 2000 | - | $14.03 M(-5.7%) |
Mar 2000 | - | $14.88 M(+17.2%) |
Dec 1999 | $12.70 M(-16.4%) | $12.70 M(+41.1%) |
Sept 1999 | - | $9.00 M(-11.8%) |
June 1999 | - | $10.20 M(-16.4%) |
Mar 1999 | - | $12.20 M(-19.7%) |
Dec 1998 | $15.20 M(+42.1%) | $15.20 M(-5.6%) |
Sept 1998 | - | $16.10 M(+98.8%) |
June 1998 | - | $8.10 M(-13.8%) |
Mar 1998 | - | $9.40 M(-12.1%) |
Dec 1997 | $10.70 M(+81.4%) | $10.70 M(+409.5%) |
Sept 1997 | - | $2.10 M(-41.7%) |
June 1997 | - | $3.60 M(-23.4%) |
Mar 1997 | - | $4.70 M(-20.3%) |
Dec 1996 | $5.90 M(+34.1%) | $5.90 M(-18.1%) |
Sept 1996 | - | $7.20 M(+200.0%) |
June 1996 | - | $2.40 M(-35.1%) |
Mar 1996 | - | $3.70 M(-15.9%) |
Dec 1995 | $4.40 M | $4.40 M |
FAQ
- What is AIM ImmunoTech annual stockholders equity?
- What is the all time high annual shareholders equity for AIM ImmunoTech?
- What is AIM ImmunoTech annual shareholders equity year-on-year change?
- What is AIM ImmunoTech quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for AIM ImmunoTech?
- What is AIM ImmunoTech quarterly shareholders equity year-on-year change?
What is AIM ImmunoTech annual stockholders equity?
The current annual shareholders equity of AIM is $10.23 M
What is the all time high annual shareholders equity for AIM ImmunoTech?
AIM ImmunoTech all-time high annual stockholders equity is $61.29 M
What is AIM ImmunoTech annual shareholders equity year-on-year change?
Over the past year, AIM annual stockholders equity has changed by -$28.23 M (-73.40%)
What is AIM ImmunoTech quarterly stockholders equity?
The current quarterly shareholders equity of AIM is $2.91 M
What is the all time high quarterly shareholders equity for AIM ImmunoTech?
AIM ImmunoTech all-time high quarterly stockholders equity is $70.97 M
What is AIM ImmunoTech quarterly shareholders equity year-on-year change?
Over the past year, AIM quarterly stockholders equity has changed by -$19.69 M (-87.12%)